Filing Details

Accession Number:
0001214659-23-000810
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-19 09:45:56
Reporting Period:
2023-01-17
Accepted Time:
2023-01-19 09:45:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1555337 D. David Meek C/O Mirati Therapeutics, Inc.
3545 Cray Court
San Diego CA 92121
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-01-17 3,179 $42.38 61,792 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 14, 2022.